776 related articles for article (PubMed ID: 22759329)
1. Eradication of Helicobacter pylori infection reduces the incidence of peptic ulcer disease in patients using nonsteroidal anti-inflammatory drugs: a meta-analysis.
Tang CL; Ye F; Liu W; Pan XL; Qian J; Zhang GX
Helicobacter; 2012 Aug; 17(4):286-96. PubMed ID: 22759329
[TBL] [Abstract][Full Text] [Related]
2. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.
de Leest HT; Steen KS; Lems WF; Bijlsma JW; van de Laar MA; Huisman AM; Vonkeman HE; Houben HH; Kadir SW; Kostense PJ; van Tulder MW; Kuipers EJ; Boers M; Dijkmans BA
Helicobacter; 2007 Oct; 12(5):477-85. PubMed ID: 17760715
[TBL] [Abstract][Full Text] [Related]
3. Use of NSAIDs and infection with Helicobacter pylori--what does the rheumatologist need to know?
Kiltz U; Zochling J; Schmidt WE; Braun J
Rheumatology (Oxford); 2008 Sep; 47(9):1342-7. PubMed ID: 18477642
[TBL] [Abstract][Full Text] [Related]
4. Interaction of Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs in gastric and duodenal ulcers.
Venerito M; Malfertheiner P
Helicobacter; 2010 Aug; 15(4):239-50. PubMed ID: 20633184
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users.
Vergara M; Catalán M; Gisbert JP; Calvet X
Aliment Pharmacol Ther; 2005 Jun; 21(12):1411-8. PubMed ID: 15948807
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for peptic ulcer bleeding in terms of Helicobacter pylori, NSAIDs, and antiplatelet agents.
Kang JM; Kim N; Lee BH; Park HK; Jo HJ; Shin CM; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Jung HC; Song IS
Scand J Gastroenterol; 2011 Nov; 46(11):1295-301. PubMed ID: 21815866
[TBL] [Abstract][Full Text] [Related]
7. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe.
Arroyo MT; Forne M; de Argila CM; Feu F; Arenas J; de la Vega J; Garrigues V; Mora F; Castro M; Bujanda L; Cosme A; Castiella A; Gisbert JP; Hervas A; Lanas A
Helicobacter; 2004 Jun; 9(3):249-54. PubMed ID: 15165261
[TBL] [Abstract][Full Text] [Related]
9. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
[TBL] [Abstract][Full Text] [Related]
10. Eradicating Helicobacter pylori in peptic ulcer disease reduces medical costs in the community.
Sone Y; Kumada T; Toyoda H; Yokoyama M; Kato M; Asaka M
Helicobacter; 2008 Oct; 13(5):346-51. PubMed ID: 19250509
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of patients with gastric outlet obstruction related to peptic ulcer disease treated with endoscopic balloon dilatation and drug therapy.
Cherian PT; Cherian S; Singh P
Gastrointest Endosc; 2007 Sep; 66(3):491-7. PubMed ID: 17640640
[TBL] [Abstract][Full Text] [Related]
12. [Role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users].
Shimada T; Yamagata M; Hiraishi H
Nihon Rinsho; 2007 Oct; 65(10):1824-9. PubMed ID: 17926531
[TBL] [Abstract][Full Text] [Related]
13. Analysis of direct medical care costs of peptic ulcer disease in a Korean tertiary medical center.
Kang JM; Seo PJ; Kim N; Lee BH; Kwon J; Lee DH; Jung HC
Scand J Gastroenterol; 2012 Jan; 47(1):36-42. PubMed ID: 22126650
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori infection and the use of NSAIDs.
Bazzoli F; De Luca L; Graham DY
Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):775-85. PubMed ID: 11566040
[TBL] [Abstract][Full Text] [Related]
15. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis.
Huang JQ; Sridhar S; Hunt RH
Lancet; 2002 Jan; 359(9300):14-22. PubMed ID: 11809181
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs, and gastroduodenal pathology: current status.
Trifan A; Stan M; Stanciu GO; Malgarinos G; Stanciu C
Rev Med Chir Soc Med Nat Iasi; 1999; 103(3-4):44-7. PubMed ID: 10756924
[TBL] [Abstract][Full Text] [Related]
17. Etiology and treatment of childhood peptic ulcer disease in Taiwan: a single center 9-year experience.
Huang SC; Sheu BS; Lee SC; Yang HB; Yang YJ
J Formos Med Assoc; 2010 Jan; 109(1):75-81. PubMed ID: 20123589
[TBL] [Abstract][Full Text] [Related]
18. Peptic ulcer disease today.
Yuan Y; Padol IT; Hunt RH
Nat Clin Pract Gastroenterol Hepatol; 2006 Feb; 3(2):80-9. PubMed ID: 16456574
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of 1,000 patients cured of Helicobacter pylori infection following an episode of peptic ulcer bleeding.
Gisbert JP; Calvet X; Cosme A; Almela P; Feu F; Bory F; Santolaria S; Aznárez R; Castro M; Fernández N; García-Grávalos R; Benages A; Cañete N; Montoro M; Borda F; Pérez-Aisa A; Piqué JM;
Am J Gastroenterol; 2012 Aug; 107(8):1197-204. PubMed ID: 22613904
[TBL] [Abstract][Full Text] [Related]
20. Is non-Helicobacter pylori, non-NSAID peptic ulcer a common cause of upper GI bleeding? A prospective study of 977 patients.
Chan HL; Wu JC; Chan FK; Choi CL; Ching JY; Lee YT; Leung WK; Lau JY; Chung SC; Sung JJ
Gastrointest Endosc; 2001 Apr; 53(4):438-42. PubMed ID: 11275883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
